Efficacy and Safety of Morinda citrifolia L. (Noni) as a Potential Anticancer Agent
- PMID: 36448674
- PMCID: PMC9716600
- DOI: 10.1177/15347354221132848
Efficacy and Safety of Morinda citrifolia L. (Noni) as a Potential Anticancer Agent
Abstract
Cancer is a major cause of morbidity and mortality worldwide and therefore there has been interest in discovering the phytoconstituents of medicinal plants exhibiting anticancer activities. Morinda citrifolia L., commonly known as Noni, has shown anticancer properties in in vitro, in vivo, and in clinical studies. A systematic review was conducted to collate scientific evidence on the anticancer properties of M. citrifolia using pre-determined keywords on 5 electronic databases: MEDLINE, CENTRAL, LILACS, Web of Science, and EBSCOHost. A total of 51 clinical and preclinical studies comprising 41 efficacy and 10 safety studies were included in this review. Our findings showed that M. citrifolia demonstrated various anticancer properties in different cancer models, via multiple mechanisms including antitumor, antiproliferative, pro-apoptotic, antiangiogenesis, antimigratory, anti-inflammatory, and immunomodulatory activities. M. citrifolia is deemed to be a potentially valuable medicinal plant in the treatment of cancer through its many intrinsic pathways. More well-designed and reported preclinical efficacy and safety studies are needed to allow for better translation into future clinical studies which could further substantiate the role of M. citriflolia in cancer treatment.
Keywords: Morinda citrifolia; cancer; chemotherapy; neoplasm; noni; tumor.
Conflict of interest statement
The author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.
Figures







Similar articles
-
Anticancer and chemopreventive potential of Morinda citrifolia L. bioactive compounds: A comprehensive update.Phytother Res. 2024 Apr;38(4):1932-1950. doi: 10.1002/ptr.8137. Epub 2024 Feb 15. Phytother Res. 2024. PMID: 38358681 Review.
-
Anticancer activity of Morinda citrifolia (Noni) fruit: a review.Phytother Res. 2012 Oct;26(10):1427-40. doi: 10.1002/ptr.4595. Epub 2012 Feb 17. Phytother Res. 2012. PMID: 22344842 Review.
-
[Literature research and discussion of Chinese medicinal properties of Morinda citrifolia].Zhongguo Zhong Yao Za Zhi. 2020 Mar;45(5):984-990. doi: 10.19540/j.cnki.cjcmm.20191230.403. Zhongguo Zhong Yao Za Zhi. 2020. PMID: 32237436 Chinese.
-
Pulmonary anti-inflammatory effects and spasmolytic properties of Costa Rican noni juice (Morinda citrifolia L.).J Ethnopharmacol. 2016 Nov 4;192:264-272. doi: 10.1016/j.jep.2016.07.038. Epub 2016 Jul 20. J Ethnopharmacol. 2016. PMID: 27451258
-
Anticancer Effects of Extracts from the Fruit of Morinda Citrifolia (Noni) in Breast Cancer Cell Lines.Drug Res (Stuttg). 2016 Mar;66(3):141-7. doi: 10.1055/s-0035-1555804. Epub 2015 Jul 9. Drug Res (Stuttg). 2016. PMID: 26158795
Cited by
-
Unveiling the potential of Muscadine grape Skin extract as an innovative therapeutic intervention in cancer treatment.J Funct Foods. 2024 May;116:106146. doi: 10.1016/j.jff.2024.106146. Epub 2024 Apr 6. J Funct Foods. 2024. PMID: 38817632 Free PMC article.
References
-
- World Health Organization. Cancer. Accessed February 21, 2022. http://www.who.int/mediacentre/factsheets/fs297/en/
-
- Ferlay J, Colombet M, Soerjomataram I, et al.. Cancer statistics for the year 2020: an overview. Int J Cancer. 2021;149:778-789. - PubMed
-
- Azizah AM, Hashimah B, Nirmal K, et al.. Malaysia National Cancer Registry Report (MNCRR) 2012-2016. Ministry of Health Malaysia; 2019.
-
- National Health and Morbidity Survey (NHMS). NCDs - non-communicable diseases healthcare demand health literacy - key findings. 2019. Accessed February 21, 2022. http://www.iku.gov.my/nhms-2019
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources